| 2024-05-14 | Sale | Evolus, Inc. EOLS | director | 6,718 0.0106% | $12.60 | $84,654 | -2.42% | |
| 2024-05-13 | Sale | Evolus, Inc. EOLS | director | 3,643 0.0059% | $12.72 | $46,356 | -0.79% | |
| 2022-05-13 | Sale | Evolus, Inc. EOLS | 5,000 0.0092% | $13.62 | $68,080 | -32.59% | ||
| 2021-01-19 | Sale | Y-mAbs Therapeutics, Inc. YMAB | director | 2,000 0.0048% | $46.52 | $93,045 | -34.59% | |
| 2020-11-18 | Sale | Y-mAbs Therapeutics, Inc. YMAB | director | 4,000 0.0063% | $28.46 | $113,850 | -25.4% | |
| 2020-11-03 | Sale | Y-mAbs Therapeutics, Inc. YMAB | director | 8,000 0.0123% | $28.08 | $224,640 | -25.41% | |
| 2019-06-13 | Evolus, Inc. EOLS | director | 4,000 0.0143% | $13.65 | $54,600 | -11.33% | ||
| 2018-12-14 | Evolus, Inc. EOLS | director | 6,000 0.0221% | $12.77 | $76,600 | +27.73% | ||
| 2017-08-16 | Ocugen, Inc. OCGN | director | 6,000 0.027% | $1.81 | $10,878 | +33.74% | ||
| 2017-05-16 | Ocugen, Inc. OCGN | director | 6,000 0.027% | $1.68 | $10,080 | +22.02% | ||
| 2016-12-15 | Ocugen, Inc. OCGN | director | 6,000 0.0359% | $1.65 | $9,900 | +10.56% | ||
| 2016-12-09 | Ocugen, Inc. OCGN | director | 10,000 0.0602% | $1.92 | $19,200 | -4.84% | ||
| 2007-05-16 | LeMaitre Vascular, Inc. LMAT | director | 800 0.0052% | $6.05 | $4,840 | +1.64% | ||
| 2007-05-15 | LeMaitre Vascular, Inc. LMAT | director | 200 0.0013% | $6.03 | $1,206 | +2.65% | ||
| 2007-05-09 | LeMaitre Vascular, Inc. LMAT | director | 1,000 0.0065% | $6.25 | $6,250 | -0.64% | ||
| 2006-10-31 | LeMaitre Vascular, Inc. LMAT | director | 2,000 0.0202% | $6.05 | $12,100 | +3.14% |